Transform CV Risk in Diabetes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This initiative supports a real-world study of practice and physician prescribing patterns and a quality improvement initiative evaluating best practices (including clinical decision support, facilitated referral to cardiometabolic team-based care model, and general educational tools/resources) to im-prove use of guideline-directed therapeutics known to lower cardiovascular risk (CV) in patients with type 2 diabetes (T2D).
Epistemonikos ID: a15af998dcd49d9778d3a29a3e8135d9f8cb8f6e
First added on: Oct 02, 2023